bisoprolol has been researched along with atenolol in 101 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (17.82) | 18.7374 |
| 1990's | 19 (18.81) | 18.2507 |
| 2000's | 26 (25.74) | 29.6817 |
| 2010's | 30 (29.70) | 24.3611 |
| 2020's | 8 (7.92) | 2.80 |
| Authors | Studies |
|---|---|
| Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Baker, JG | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Abraham, MH; Acree, WE; Ibrahim, A | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Bard, B; Carrupt, PA; Martel, S | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Charlton, SJ; Dickson, CJ; Duca, JS; Fairhurst, RA; Hornak, V; McKay, DJ; Pearlstein, RA; Reilly, J; Sandham, DA; Shaw, D; Sykes, DA; Velez-Vega, C | 1 |
| Chang, Q; Chen, Z; Hu, G; Hu, L; Li, Q; Long, J | 1 |
| Buchner-Moell, D; de Muinck, ED; Lie, KI; van de Ven, LL | 1 |
| Antonacci, A; Bokor, D; Pirrelli, A; Prandi, P; Vulpis, V | 1 |
| Akhlaghi, S; Haffner, CA; Kendall, MJ | 1 |
| Irvine, NA; Lipworth, BJ; McDevitt, DG | 1 |
| Dixon, MS; Sheridan, DJ; Thomas, P | 1 |
| Eichwede, F; Grote, B; Komar, K; Müller, R; Tarnow, J | 1 |
| Brodde, OE; Deighton, NM; Khamssi, M; Motomura, S; Zerkowski, HR | 1 |
| Anderson, OK; Berglund, G; Brunner, HR; Bühler, FR; Distler, A; Fogari, R; Mimran, A; Philipp, T; Scherrer, U; van Brummelen, P | 1 |
| Lithell, H; Selinus, I; Vessby, B; Weiner, L | 1 |
| Kohli, RS; Lahiri, A; Raftery, EB | 1 |
| Belz, GG; Palm, D; Wellstein, A | 1 |
| Belz, GG; Bühring, KU; Leopold, G; Pabst, J; Palm, D; Wellstein, A | 1 |
| Chang, PC; van Brummelen, P; van Veen, S; Vermeij, P | 1 |
| Bolli, P; Bühler, FR; Ji, BH; Linder, L; Müller, FB | 1 |
| Chang, PC; van Brummelen, P; van der Krogt, JA; van Veen, S; Vermeij, P | 1 |
| Hughes, LO; Kardash, MM; Khurmi, NS; Kohli, RS; Lahiri, A; Raftery, EB | 1 |
| Bühring, KU; Leopold, G; Pabst, J; Simane, Z; Ungethüm, W; Wiemann, H | 1 |
| Bühring, KU; Garbe, A | 1 |
| Bethge, H; Dorow, P; Tönnesmann, U | 1 |
| Belz, GG; Butzer, R; Palm, D; Pett, B; Polsak, R; Wellstein, A | 1 |
| Ioannides, C; Johnston, A; Lewis, R; Maclean, D; McDevitt, DG | 1 |
| Camm, AJ; Dymond, DS; Maltz, MB; Nathan, AW | 1 |
| Frithz, G; Hosie, J; Lithell, H; Selinus, I; Weiner, L | 1 |
| Haeusler, G; Harting, J; Schliep, HJ; Schulze, E | 1 |
| Collart, F; Degaute, JP; Leeman, M; Mélot, C; Peeters, L; van de Borne, P; Vandenhoven, G | 1 |
| MacDonald, TM; Maclean, D; McDevitt, DG; Peebles, L; Prasad, N; Wheeldon, NM | 1 |
| Prásek, J; Soucek, M; Spinarová, L | 1 |
| Fagan, TC; Kaplan, NM; Kazempour, MK; Lefkowitz, MP; Neutel, JM; Papademetriou, V; Ram, CV; Smith, DH; Weber, MA | 1 |
| Kazempour, MK; Lefkowitz, MP; Neutel, JM; Ram, CV; Smith, DH; Weber, MA | 1 |
| Marín Huerta, E; Rayo Llerena, I | 1 |
| Kurosawa, H; Taira, N; Yanagisawa, T | 1 |
| Berthelsen, PG; Lippert, FK; Yndgaard, S | 1 |
| Danser, AH; Hense, HW; Holmer, SR; Mayer, B; Riegger, GA; Schunkert, H | 1 |
| Corradi, L; Fogari, R; Lusardi, P; Mugellini, A; Preti, P; Zoppi, A | 1 |
| Defoor, JG; Fagard, RH; Lacante, PH; Lijnen, P; Peeters, BY; Schepers, D; Vanhees, L | 1 |
| Brodner, G; Buerkle, H; Möllhoff, T; Van Aken, H | 1 |
| Laurent, SA; London, GM; Safar, ME | 1 |
| Bethge, H; Disselhoff, G; Dorow, P; Thalhofer, S; Wagner, G | 1 |
| Brooks, NH; Hutchinson, IV; Jenkins, NP; Keevil, BG | 1 |
| Julve, R; Miralles, A; Pascual, JM; Redon, J; Rovira, E | 1 |
| Cruickshank, JM | 1 |
| Kendall, MJ; Nuttall, SL; Routledge, HC | 1 |
| Abou-Sekkina, MM; El-Ries, MA; Hassan, SS; Wassel, A | 1 |
| Abakumov, IuE; Batutina, AM; Kukes, VG; Mamaev, VI; Ostroumova, OD; Zykova, AA | 1 |
| Kanazawa, M; Kataoka, H; Kohzuki, M; Kurosawa, H; Minami, N; Mori, N; Nagasaka, M; Yoshikawa, T | 1 |
| Berry, C; Corbett, W; Fleisher, LA; Poldermans, D | 1 |
| Eschenhagen, T; Rau, T; Wuttke, H | 1 |
| Bozhko, AA; Kanopskiĭ, SG; Staritskiĭ, AG | 1 |
| Barthelet, M; Baumann, C; Bonnet, D; Chevallier, B; Collignon, P; Dulac, Y; Edouard, T; Faivre, L; Germain, D; Jondeau, G; Khau Van Kien, P; Lacombe, D; Ladouceur, M; Leheup, B; Lemerrer, M; Lupoglazoff, JM; Magnier, S; Muti, C; Plauchu, PH; Raffestin, B; Sassolas, F; Schleich, JM; Sidi, D; Themar-Noël, C; Varin, J; Wolf, JE | 1 |
| Cai, Y; Jia, J; Li, S; Liu, G; Liu, Y; Pan, C; Ren, J; Yu, C | 1 |
| Aronson, JK | 1 |
| Abildstrøm, SZ; Andersen, SS; Folke, F; Fosbøl, E; Gislason, GH; Hansen, ML; Køber, L; Madsen, M; Rasmussen, S; Schramm, TK; Sørensen, R; Torp-Pedersen, C | 1 |
| Sal'nikov, EV | 1 |
| Alonso, RM; Ferreirós, N; Gonzalez, O; Iriarte, G; Jiménez, RM; Maguregui, MI; Rico, E | 1 |
| Dronova, EP; Lopatin, IuM | 1 |
| Benvenuto, A; Masciocco, L; Prencipe, G; Riccioni, G; Rizzo, U; Russi, C; Speziale, G; Ventra, S | 1 |
| DiNicolantonio, JJ; Fares, H; Lavie, CJ; Menezes, AR; O'Keefe, JH | 1 |
| Antenore, A; Bagnoli, P; Dicembrini, I; Filippi, L; Mannucci, E; Marchionni, N; Monami, M; Rotella, CM; Sgrilli, F; Ungar, A | 1 |
| Choi, D; Jeon, D; Kim, BW; Kwan, J; Lee, SY; Park, S; Park, SW; Rhee, MY | 1 |
| Ashes, C; Beattie, WS; Hare, GM; Judelman, S; Mazer, CD; Tait, G; Wijeysundera, DN | 1 |
| Eisenach, JC | 1 |
| Chen, DR; Chen, EZ; Gao, PJ; Li, Y; Wang, RY; Zhou, WJ; Zhu, DL | 1 |
| Galantine, V; Gosse, P; Lacraz, A; Rubin, S | 1 |
| Furuichi, Y; Sakamoto, A | 1 |
| Bronheim, D; Wicker, JF | 1 |
| Ashes, C; Beattie, WS; Hare, GM; Judelman, S; Mazer, CD; Tait, G; Wijeysundera, D | 1 |
| Koide, S; Nakano, K; Sadamatsu, K; Yoshida, K | 1 |
| Abd El-Hady, D; Albishri, HM; Tayeb, RA | 1 |
| Alfie, J; Aparicio, LS; Barochiner, J; Cuffaro, PE; Elizondo, CM; Giunta, DH; Morales, MS; Rada, MA; Tortella, JJ; Waisman, GD | 1 |
| van Klei, WA | 1 |
| Agharazii, M; Dupuis, D; Goupil, R; Madore, F; Troyanov, S | 1 |
| Chen, RJ; Chu, H; Tsai, LW | 1 |
| Komal, C; Prachi, S; Priti, MJ | 1 |
| Addison, D; Alam, M; Jneid, H; Kayani, W; Lakkis, N; Misra, A; Pham, D; Resar, J | 1 |
| Falcon, M; Fernandez-Lopez, L; Luna, A; Mancini, R; Pellegrini, M; Rotolo, MC | 1 |
| Boerwinkle, E; Chapman, AB; Cooper-DeHoff, RM; El Rouby, N; Fyhrquist, F; Garofalidou, T; Glorioso, N; Glorioso, V; Gong, Y; Hiltunen, TP; Johnson, JA; Kontula, KK; McDonough, CW; Munroe, PB; Pepine, CJ; Salvi, E; Singh, S; Turner, ST; Wang, Z; Warren, HR; Zaninello, R | 1 |
| Andrews, LM; Koch, BCP; van der Nagel, BCH; van Domburg, B | 1 |
| Ashidate, K; Fujita, Y; Ito, T; Kikuchi, K; Kikuchi, T; Kikuchi, Y; Komano, H; Liu, J; Maeda, T; Niibori, S; Nishikata, D; Shen, X; Terakawa, T; Zou, K | 1 |
| Ansorge, M; Dovhunová, M; Galić, N; Habinovec, I; Pocrnić, M; Tesařová, E | 1 |
| Jacobsen, SJ; Kalantar-Zadeh, K; Kovesdy, CP; Lee, MS; Neyer, JR; Shaw, SF; Shi, J; Sim, JJ; Zhou, H | 1 |
| Chen, YW; Hsu, CW; Huang, KY; Lin, CH; Lin, PY; Matsuoka, YJ; Stubbs, B; Su, KP; Tseng, PT; Tu, YK; Wu, YC | 1 |
| Ballotari, M; Gottardo, R; Tagliaro, F; Taus, F; Utzeri, C | 1 |
| Gedde-Dahl, A; Molden, E; Spigset, O | 1 |
| Carlo, MJ; Patrick, AL | 1 |
13 review(s) available for bisoprolol and atenolol
| Article | Year |
|---|---|
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1988 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Silent myocardial ischemia. Arguments against treatment].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Atenolol; Bisoprolol; Calcium Channel Blockers; Clinical Trials as Topic; Electrocardiography; Electrocardiography, Ambulatory; Exercise Test; Humans; Multicenter Studies as Topic; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Nifedipine; Prognosis; Sympatholytics | 1996 |
[Efficacy of oncologic surgery. Does anesthesia influence the postoperative outcome?].
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Aged; Anesthesia; Atenolol; Bisoprolol; Clinical Trials as Topic; Combined Modality Therapy; Contraindications; Dexmedetomidine; Hemodynamics; Humans; Imidazoles; Intraoperative Complications; Multicenter Studies as Topic; Neoplasms; Postoperative Complications; Preoperative Care; Risk Factors; Time Factors; Treatment Outcome | 2001 |
Beta-blockade and brachial artery hemodynamics in hypertension.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Bisoprolol; Brachial Artery; Forearm; Humans; Hypertension; Receptors, Adrenergic, beta-1 | 1990 |
Beta-blockers and diabetes: the bad guys come good.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Bisoprolol; Coronary Disease; Diabetes Mellitus, Type 2; Humans; Hypertension; Metoprolol; Myocardial Infarction; Prognosis; Propranolol | 2002 |
[Genetic polymorphisms in drug metabolizing enzymes--impact on treatment with beta-blockers].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alleles; Atenolol; Benzopyrans; Biotransformation; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Cytochrome P-450 CYP2D6; Ethanolamines; Female; Genotype; Humans; Male; Metoprolol; Mutation; Nebivolol; Pharmacogenetics; Phenotype; Polymorphism, Genetic; Propanolamines; Risk Factors; Time Factors | 2004 |
Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol).
Topics: Adrenergic beta-1 Receptor Antagonists; Atenolol; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; Ethanolamines; Global Health; Humans; Metoprolol; Myocardial Infarction; Nebivolol; Platelet Aggregation Inhibitors; Propanolamines; Survival Rate; Treatment Outcome | 2013 |
Further data on beta-blockers and cancer risk: observational study and meta-analysis of randomized clinical trials.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; Diabetes Mellitus; Ethanolamines; Female; Humans; Insulin; Insulin Glargine; Insulin, Long-Acting; Male; Metformin; Myocardial Ischemia; Nebivolol; Neoplasms; Propanolamines; Risk | 2013 |
[Perioperative cardiovascular evaluation and management for noncardiac surgery].
Topics: Adrenergic beta-Antagonists; Anesthesia; Atenolol; Bisoprolol; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Indoles; Intraoperative Complications; Metoprolol; Monitoring, Intraoperative; Morpholines; Myocardial Infarction; Myocardial Ischemia; Perioperative Care; Postoperative Complications; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Risk Assessment; Urea | 2014 |
Outcomes of beta blocker use in cocaine-associated chest pain: a meta-analysis.
Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Carvedilol; Cocaine; Humans; Metoprolol; Propanolamines; Propranolol | 2018 |
Genome-Wide Meta-Analysis of Blood Pressure Response to β
Topics: ADP-ribosyl Cyclase; Adrenergic beta-1 Receptor Antagonists; Antigens, CD; Atenolol; Bisoprolol; Black People; Blood Pressure; Genome-Wide Association Study; GPI-Linked Proteins; Humans; Hypertension; Metoprolol; Mutation, Missense; Pharmacogenetics; Pharmacogenomic Variants; Polymorphism, Single Nucleotide; Treatment Outcome; White People | 2019 |
Do beta-adrenergic blocking agents increase asthma exacerbation? A network meta-analysis of randomized controlled trials.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Cardiovascular Diseases; Celiprolol; Disease Progression; Female; Humans; Incidence; Infusions, Intravenous; Male; Practolol; Propranolol; Randomized Controlled Trials as Topic; Risk; Sotalol; Status Asthmaticus; Timolol | 2021 |
36 trial(s) available for bisoprolol and atenolol
| Article | Year |
|---|---|
Comparison of the safety and efficacy of bisoprolol versus atenolol in stable exercise-induced angina pectoris: a Multicenter International Randomized Study of Angina Pectoris (MIRSA).
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Atenolol; Bisoprolol; Double-Blind Method; Electrocardiography; Exercise; Exercise Test; Female; Humans; Male; Middle Aged; Nitroglycerin; Propanolamines | 1992 |
[The effects of bisoprolol and atenolol on glucose metabolism in hypertensive patients with non-insulin-dependent diabetes mellitus].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Bisoprolol; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Tolerance; Female; Glycosuria; Humans; Hypertension; Male; Middle Aged; Propanolamines; Time Factors | 1991 |
Assessment of beta-1 selectivity of bisoprolol and atenolol by means of their influence on the lipolytic response to an infusion of terbutaline.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Bisoprolol; Dose-Response Relationship, Drug; Fatty Acids, Nonesterified; Female; Humans; Infusions, Intravenous; Lipolysis; Male; Propanolamines; Single-Blind Method; Terbutaline | 1991 |
A dose-ranging study to evaluate the beta 1-adrenoceptor selectivity of bisoprolol.
Topics: Adrenergic beta-Antagonists; Adult; Analysis of Variance; Atenolol; Bisoprolol; Blood Pressure; Cardiac Output; Dose-Response Relationship, Drug; Heart Rate; Humans; Isoproterenol; Male; Nadolol; Propanolamines; Single-Blind Method; Statistics as Topic; Tremor | 1991 |
A randomized double-blind study of bisoprolol versus atenolol in mild to moderate essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Bisoprolol; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Posture; Propanolamines; Random Allocation | 1990 |
[Preoperative treatment with beta-receptor blockers and isoflurane anesthesia. Hemodynamic interactions in patients with coronary disease].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Anesthesia, Inhalation; Atenolol; Bisoprolol; Coronary Disease; Drug Interactions; Hemodynamics; Humans; Isoflurane; Metoprolol; Middle Aged; Preanesthetic Medication; Propanolamines | 1990 |
Double-blind comparison of the cardioselective beta-blockers bisoprolol and atenolol in hypertension: the Bisoprolol International Multicenter Study (BIMS).
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Bisoprolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female; Heart; Humans; Hypertension; Male; Middle Aged; Organ Specificity; Propanolamines; Self Concept | 1986 |
A comparison of the effects of bisoprolol and atenolol on lipoprotein concentrations and blood pressure.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Bisoprolol; Blood Pressure; Female; Humans; Hypertension; Lipoproteins; Male; Middle Aged; Osmolar Concentration; Propanolamines | 1986 |
Management of chronic stable angina with once-daily bisoprolol or atenolol and long-term efficacy of bisoprolol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Bisoprolol; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Propanolamines; Time Factors | 1986 |
Double-blind comparison of the beta 1-selectivity of single doses of bisoprolol and atenolol.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Bisoprolol; Blood Pressure; Double-Blind Method; Epinephrine; Forearm; Heart Rate; Hemodynamics; Humans; Isoproterenol; Male; Propanolamines; Regional Blood Flow | 1986 |
Cardiac and vascular beta-adrenoceptor-mediated responses before and during treatment with bisoprolol or atenolol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Bisoprolol; Blood Pressure; Blood Vessels; Forearm; Heart; Heart Rate; Humans; Male; Middle Aged; Propanolamines; Regional Blood Flow; Renin | 1986 |
Beta 1-adrenoceptor selectivity of single oral doses of bisoprolol and atenolol.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Atenolol; Bisoprolol; Blood Glucose; Electrolytes; Epinephrine; Exercise Test; Hemodynamics; Humans; Infusions, Intravenous; Injections, Intra-Arterial; Isoproterenol; Lactates; Male; Propanolamines; Receptors, Adrenergic, beta; Regional Blood Flow | 1988 |
Efficacy of once daily bisoprolol in stable angina pectoris: an objective comparison with atenolol and long term follow-up.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Bisoprolol; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Exercise Test; Female; Follow-Up Studies; Hemodynamics; Humans; Male; Middle Aged; Propanolamines; Random Allocation | 1985 |
Pharmacodynamic profile of bisoprolol, a new beta 1-selective adrenoceptor antagonist.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Bisoprolol; Dose-Response Relationship, Drug; Heart Rate; Humans; Male; Metoprolol; Physical Exertion; Propanolamines; Propranolol; Time Factors | 1986 |
Effects of single oral doses of bisoprolol and atenolol on airway function in nonasthmatic chronic obstructive lung disease and angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Airway Resistance; Angina Pectoris; Atenolol; Bisoprolol; Double-Blind Method; Female; Hemodynamics; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Propanolamines; Random Allocation | 1986 |
Reduction of exercise tachycardia in man after propranolol, atenolol and bisoprolol in comparison to beta-adrenoceptor occupancy.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Bisoprolol; Double-Blind Method; Exercise Test; Heart Rate; Humans; Male; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Tachycardia | 1987 |
A comparison of bisoprolol and atenolol in the treatment of mild to moderate hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Bisoprolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Propanolamines; Random Allocation; Time Factors | 1988 |
A comparison of once daily bisoprolol, 5 and 10 mg, and atenolol 100 mg in the treatment of angina pectoris.
Topics: Aged; Angina Pectoris; Atenolol; Bisoprolol; Chronic Disease; Clinical Trials as Topic; Drug Administration Schedule; Electrocardiography; Exercise Test; Female; Humans; Male; Middle Aged; Propanolamines | 1987 |
Efficacy and safety of bisoprolol and atenolol in patients with mild to moderate hypertension: a double-blind, parallel group international multicentre study.
Topics: Adult; Aged; Atenolol; Bisoprolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Patient Compliance; Propanolamines; Random Allocation | 1987 |
Bisoprolol and atenolol in essential hypertension: effects on systemic and renal hemodynamics and on ambulatory blood pressure.
Topics: Adult; Atenolol; Bisoprolol; Blood Pressure; Cardiac Output; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Male; Middle Aged; Monitoring, Physiologic; Renal Circulation; Vascular Resistance | 1993 |
A double-blind comparison of bisoprolol and atenolol in patients with essential hypertension.
Topics: Atenolol; Bisoprolol; Blood Pressure; Cross-Over Studies; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Time Factors | 1995 |
[Atenolol and bisoprolol in the treatment of mild and moderately severe hypertension].
Topics: Adult; Atenolol; Bisoprolol; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Male | 1993 |
Application of ambulatory blood pressure monitoring in differentiating between antihypertensive agents.
Topics: Adult; Aged; Aged, 80 and over; Atenolol; Bisoprolol; Blood Pressure; Blood Pressure Determination; Blood Pressure Monitors; Diastole; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Placebos; Single-Blind Method; Systole | 1993 |
Comparison of bisoprolol with atenolol for systemic hypertension in four population groups (young, old, black and nonblack) using ambulatory blood pressure monitoring. Bisoprolol Investigators Group.
Topics: Adult; Age Factors; Aged; Ambulatory Care; Atenolol; Bisoprolol; Black People; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Monitoring, Physiologic; Treatment Outcome | 1993 |
[Do cardioselective beta-antagonists block the cardiac beta-receptor function also in the long run?].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Bisoprolol; Cardiotonic Agents; Hemodynamics; Humans; Isoproterenol; Male; Metoprolol; Middle Aged; Receptors, Adrenergic, beta; Time Factors | 1998 |
Beta-blocker effects on plasma lipids during prolonged treatment of hypertensive patients with hypercholesterolemia.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Analysis of Variance; Atenolol; Bisoprolol; Celiprolol; Double-Blind Method; Humans; Hypercholesterolemia; Hypertension; Lipids; Male; Middle Aged; Propranolol | 1999 |
Effect of bisoprolol and atenolol on endurance exercise capacity in healthy men.
Topics: Adrenergic beta-Antagonists; Adult; Analysis of Variance; Atenolol; Bisoprolol; Blood; Cross-Over Studies; Double-Blind Method; Exercise; Hemodynamics; Humans; Male; Physical Endurance; Reference Values; Regression Analysis; Respiration; Rest | 2000 |
Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Airway Resistance; Angina Pectoris; Atenolol; Bisoprolol; Blood Pressure; Bronchitis; Cross-Over Studies; Double-Blind Method; Exercise Test; Female; Forced Expiratory Volume; Heart Rate; Humans; Male; Middle Aged; Receptors, Adrenergic, beta-1 | 1990 |
Factors related to the occurrence of microalbuminuria during antihypertensive treatment in essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Bisoprolol; Calcium Channel Blockers; Enalapril; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Nifedipine; Proportional Hazards Models; Regression Analysis; Risk Factors; Treatment Outcome | 2002 |
A comparison of the beta1-selectivity of three beta1-selective beta-blockers.
Topics: Administration, Oral; Adolescent; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Analysis of Variance; Atenolol; Benzopyrans; Bisoprolol; Blood Glucose; Blood Pressure; Double-Blind Method; Ethanolamines; Female; Heart Rate; Humans; Infusions, Parenteral; Insulin; Male; Nebivolol; Potassium; Terbutaline | 2003 |
[Efficacy and safety of different beta-blockers in patients with isolated systolic hypertension associated with diabetes mellitus and obstructive pulmonary diseases].
Topics: Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Diabetes Complications; Diabetes Mellitus; Female; Humans; Hypertension; Lung Diseases, Obstructive; Male; Metoprolol; Middle Aged; Treatment Outcome | 2003 |
[Clinical-pharmacoeconomical aspects of ß-adrenoblockers use in patients with ischemic heart disease undergoing coronary artery bypass grafting].
Topics: Adrenergic beta-1 Receptor Antagonists; Angina Pectoris; Atenolol; Bisoprolol; Comparative Effectiveness Research; Coronary Angiography; Coronary Artery Bypass; Cost Savings; Exercise Test; Female; Graft Occlusion, Vascular; Humans; Male; Metoprolol; Middle Aged; Patient Readmission; Time; Treatment Outcome | 2010 |
Ivabradine improves all aspects of quality of life assessed with the 36-item short form health survey in subjects with chronic ischemic heart disease compared with beta-blockers.
Topics: Adrenergic beta-Antagonists; Aged; Angina, Stable; Atenolol; Benzazepines; Bisoprolol; Carbazoles; Carvedilol; Female; Health Surveys; Humans; Ivabradine; Male; Middle Aged; Propanolamines; Quality of Life | 2013 |
Further data on beta-blockers and cancer risk: observational study and meta-analysis of randomized clinical trials.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; Diabetes Mellitus; Ethanolamines; Female; Humans; Insulin; Insulin Glargine; Insulin, Long-Acting; Male; Metformin; Myocardial Ischemia; Nebivolol; Neoplasms; Propanolamines; Risk | 2013 |
A prospective, randomized, open-label, active-controlled, clinical trial to assess central haemodynamic effects of bisoprolol and atenolol in hypertensive patients.
Topics: Adult; Antihypertensive Agents; Atenolol; Bisoprolol; Blood Pressure; Female; Hemodynamics; Humans; Male; Middle Aged; Prospective Studies | 2013 |
A randomized controlled study on the effects of bisoprolol and atenolol on sympathetic nervous activity and central aortic pressure in patients with essential hypertension.
Topics: Adult; Antihypertensive Agents; Arterial Pressure; Atenolol; Baroreflex; Bisoprolol; Essential Hypertension; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2013 |
53 other study(ies) available for bisoprolol and atenolol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Algorithms; Animals; Cell Line; CHO Cells; Cricetinae; Dioxoles; Humans; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3 | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Lipophilicity of basic drugs measured by hydrophilic interaction chromatography.
Topics: Chemistry, Pharmaceutical; Chromatography; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Pharmaceutical Preparations; Solubility; Technology, Pharmaceutical | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Uncoupling the Structure-Activity Relationships of β2 Adrenergic Receptor Ligands from Membrane Binding.
Topics: Binding Sites; Cell Membrane; Dose-Response Relationship, Drug; Humans; Ligands; Models, Molecular; Molecular Structure; Receptors, Adrenergic, beta-2; Structure-Activity Relationship | 2016 |
Drug repurposing and rediscovery: Design, synthesis and preliminary biological evaluation of 1-arylamino-3-aryloxypropan-2-ols as anti-melanoma agents.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; Drug Repositioning; Drug Screening Assays, Antitumor; Humans; Melanoma; Molecular Docking Simulation; Molecular Structure; Propanols; Skin Neoplasms; Structure-Activity Relationship; Tumor Cells, Cultured | 2020 |
Differential regulation of human cardiac beta-adrenergic and muscarinic receptors by chronic beta-adrenoceptor antagonist treatment.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Bisoprolol; Electric Stimulation; Humans; In Vitro Techniques; Iodocyanopindolol; Metoprolol; Middle Aged; Myocardial Contraction; Myocardium; N-Methylscopolamine; Parasympatholytics; Pindolol; Propanolamines; Receptors, Adrenergic, beta; Receptors, Muscarinic; Scopolamine Derivatives | 1990 |
Affinity and selectivity of beta-adrenoceptor antagonists in vitro.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Betaxolol; Binding, Competitive; Bisoprolol; Propanolamines; Propranolol; Rats; Salivary Glands; Tritium | 1986 |
Concentration kinetics of propranolol, bisoprolol, and atenolol in humans assessed with chemical detection and a subtype-selective beta-adrenoceptor assay.
Topics: Adrenergic beta-Antagonists; Adult; Animals; Atenolol; Bisoprolol; Chemistry, Physical; Humans; Kinetics; Male; Osmolar Concentration; Propanolamines; Propranolol; Rats; Receptors, Adrenergic, beta | 1986 |
Determination of the new beta-blocker bisoprolol and of metoprolol, atenolol and propranolol in plasma and urine by high-performance liquid chromatography.
Topics: Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Chromatography, High Pressure Liquid; Humans; Indicators and Reagents; Kinetics; Metoprolol; Propanolamines; Propranolol | 1986 |
Antagonistic effects of bisoprolol on several beta-adrenoceptor-mediated actions in anaesthetized cats.
Topics: Anesthesia; Animals; Atenolol; Bisoprolol; Blood Pressure; Bronchi; Cardiovascular Physiological Phenomena; Cardiovascular System; Cats; Female; Heart Rate; Isoproterenol; Male; Muscle Contraction; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Respiration | 1986 |
Biphasic antagonisms by beta-blockers against positive inotropic response through beta1-adrenoceptors in isolated canine right ventricular muscles: possible involvement of two beta 1-adrenoceptor subtypes.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Bisoprolol; Dogs; Dose-Response Relationship, Drug; Ethanolamines; Female; Isoproterenol; Male; Myocardial Contraction; Myocardium; Nadolol; Papillary Muscles; Receptors, Adrenergic, beta-1; Stimulation, Chemical | 1996 |
Beta adrenergic blockers lower renin in patients treated with ACE inhibitors and diuretics.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Bisoprolol; Coronary Disease; Diuretics; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Male; Metoprolol; Middle Aged; Multivariate Analysis; Renin; Statistics, Nonparametric | 1998 |
Beta-blockers are associated with lower C-reactive protein concentrations in patients with coronary artery disease.
Topics: Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Body Mass Index; C-Reactive Protein; Cholesterol, HDL; Coronary Disease; Female; Humans; Male; Middle Aged; Risk Factors | 2002 |
Polymeric matrix membrane sensors for sensitive potentiometric determination of some beta-blockers in pharmaceutical preparations.
Topics: Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Indicators and Reagents; Ions; Metoprolol; Phosphates; Polyvinyl Chloride; Potentiometry; Propranolol; Sensitivity and Specificity; Timolol; Tungsten Compounds | 2003 |
Effects of exercise and beta-blocker on blood pressure and baroreflexes in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Baroreflex; Bisoprolol; Blood Pressure; Body Weight; Heart Rate; Hypertension; Hypertrophy, Left Ventricular; Male; Physical Conditioning, Animal; Rats; Rats, Inbred SHR; Tail | 2003 |
Cost-effectiveness of differing perioperative beta-blockade strategies in vascular surgery patients.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aortic Aneurysm, Abdominal; Atenolol; Bisoprolol; Cost-Benefit Analysis; Decision Support Techniques; Humans; Infusions, Intravenous; Metoprolol; Perioperative Care; Postoperative Complications; Propanolamines; Treatment Outcome; Vascular Surgical Procedures | 2004 |
[Correction of baroreflex sensitivity impairment and efficacy of prevention of sudden arrhythmic death in patients with postinfarction left ventricular dysfunction].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agents; Arrhythmias, Cardiac; Atenolol; Baroreflex; Bisoprolol; Carbazoles; Carvedilol; Data Interpretation, Statistical; Death, Sudden, Cardiac; Drug Therapy, Combination; Echocardiography; Electrocardiography; Female; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Perindopril; Phenylephrine; Propanolamines; Time Factors; Ventricular Dysfunction, Left | 2004 |
[Recommendations for the medical management of aortic complications of Marfan's syndrome].
Topics: Adrenergic beta-Antagonists; Aortic Aneurysm; Aortic Dissection; Atenolol; Bisoprolol; Calcium Channel Blockers; Drug Therapy, Combination; France; Humans; Marfan Syndrome; Societies, Medical; Treatment Outcome; Verapamil | 2006 |
Simultaneous determination of ten antiarrhythic drugs and a metabolite in human plasma by liquid chromatography--tandem mass spectrometry.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atenolol; Bisoprolol; Carbazoles; Carvedilol; Chromatography, Liquid; Diltiazem; Humans; Metoprolol; Mexiletine; Molecular Structure; Propanolamines; Propranolol; Reproducibility of Results; Sotalol; Tandem Mass Spectrometry; Verapamil | 2007 |
Changing beta-blockers in heart failure: when is a class not a class?
Topics: Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Carbazoles; Carvedilol; Heart; Heart Failure; Humans; Natriuretic Peptide, Brain; Propanolamines | 2008 |
Mortality and reinfarction among patients using different beta-blockers for secondary prevention after a myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Bisoprolol; Female; Humans; Kaplan-Meier Estimate; Male; Metoprolol; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Recurrence; Registries; Sotalol | 2009 |
Heart rate variability in rats with experimental chronic heart failure and long-term exposure to beta-adrenoblockers.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Benzopyrans; Bisoprolol; Ethanolamines; Heart Failure; Heart Rate; Male; Metoprolol; Nebivolol; Pindolol; Propranolol; Rats | 2009 |
LC-MS/MS method for the determination of several drugs used in combined cardiovascular therapy in human plasma.
Topics: Ammonium Sulfate; Atenolol; Bisoprolol; Cardiovascular Agents; Chromatography, Liquid; Drug Stability; Formates; Humans; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2010 |
Selective β1-antagonism with bisoprolol is associated with fewer postoperative strokes than atenolol or metoprolol: a single-center cohort study of 44,092 consecutive patients.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Atenolol; Bisoprolol; Cohort Studies; Female; Humans; Male; Metoprolol; Ontario; Postoperative Complications; Retrospective Studies; Stroke | 2013 |
Patient safety: anesthesiology contributions and supplements to the American Society of Anesthesiologists' Annual Meeting.
Topics: Adrenergic beta-1 Receptor Antagonists; Atenolol; Bisoprolol; Female; Humans; Male; Metoprolol; Postoperative Complications; Stroke | 2013 |
Malignant hypertension and interferon-beta: a case report.
Topics: Adult; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Bisoprolol; Female; Humans; Hypertension, Malignant; Immunologic Factors; Interferon-beta; Irbesartan; Multiple Sclerosis; Ramipril; Renin-Angiotensin System; Tetrazoles | 2014 |
Does β selectivity really affect outcome?
Topics: Adrenergic beta-1 Receptor Antagonists; Atenolol; Bisoprolol; Female; Humans; Male; Metoprolol; Postoperative Complications; Stroke | 2014 |
In reply.
Topics: Adrenergic beta-1 Receptor Antagonists; Atenolol; Bisoprolol; Female; Humans; Male; Metoprolol; Postoperative Complications; Stroke | 2014 |
Heart rate control with single administration of a long-acting β-blocker at bedtime before coronary computed tomography angiography.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Bisoprolol; Coronary Angiography; Female; Heart Rate; Humans; Male; Middle Aged; Preoperative Period; Retrospective Studies; Time Factors; Tomography, X-Ray Computed | 2015 |
Cyclodextrin Micellar LC for Direct Selective Analysis of Combined Dosage Drugs in Urine.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Adult; Antihypertensive Agents; Atenolol; beta-Cyclodextrins; Bisoprolol; Chlorthalidone; Chromatography, Liquid; Drug Combinations; Humans; Hydrochlorothiazide; Limit of Detection; Male; Micelles; Sodium Dodecyl Sulfate | 2015 |
Comparison of atenolol versus bisoprolol with noninvasive hemodynamic and pulse wave assessment.
Topics: Anthropometry; Antihypertensive Agents; Atenolol; Biomarkers; Bisoprolol; Cardiography, Impedance; Cross-Over Studies; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Pulse Wave Analysis; Risk Factors; Vascular Resistance; Vascular Stiffness | 2015 |
[Which is the preferred perioperative beta-blocker?].
Topics: Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Humans; Metoprolol; Perioperative Care; Practice Guidelines as Topic; Risk Assessment; Risk Factors; Surgical Procedures, Operative | 2015 |
Heart rate dependent and independent effects of beta-blockers on central hemodynamic parameters: a propensity score analysis.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Atenolol; Bisoprolol; Blood Pressure; Cross-Sectional Studies; Female; Heart Rate; Humans; Hypertension; Male; Metoprolol; Middle Aged; Propensity Score; Pulse Wave Analysis | 2016 |
Impact of Beta-Blocker Initiation Timing on Mortality Risk in Patients With Diabetes Mellitus Undergoing Noncardiac Surgery: A Nationwide Population-Based Cohort Study.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Bisoprolol; Carbazoles; Carvedilol; Cohort Studies; Databases, Factual; Diabetes Mellitus, Type 2; Female; Hospital Mortality; Humans; Male; Metoprolol; Middle Aged; Mortality; Odds Ratio; Perioperative Care; Propanolamines; Propensity Score; Protective Factors; Risk Factors; Surgical Procedures, Operative; Taiwan; Time Factors | 2017 |
Influence of Peroxide Impurities in Povidone on the Stability of Selected β-Blockers with the Help of HPLC.
Topics: Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Carbazoles; Carvedilol; Chromatography, High Pressure Liquid; Drug Contamination; Drug Stability; Excipients; Metoprolol; Oxidation-Reduction; Peroxides; Povidone; Propanolamines | 2017 |
Development and Validation of a Method for the Analysis of Bisoprolol and Atenolol in Human Bone.
Topics: Atenolol; Bisoprolol; Bone and Bones; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Humans; Reproducibility of Results; Solid Phase Extraction | 2019 |
High-throughput quantification of ten antiarrhythmic drugs in human plasma using UPLC-MS/MS.
Topics: Anti-Arrhythmia Agents; Atenolol; Bisoprolol; Carvedilol; Chromatography, High Pressure Liquid; Diltiazem; Flecainide; High-Throughput Screening Assays; Humans; Lidocaine; Metoprolol; Propranolol; Reproducibility of Results; Sotalol; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Verapamil | 2019 |
Interaction between Angiotensin Receptor and β-Adrenergic Receptor Regulates the Production of Amyloid β-Protein.
Topics: Adrenergic beta-Antagonists; Amyloid beta-Peptides; Angiotensin II Type 1 Receptor Blockers; Animals; Atenolol; Bisoprolol; Cells, Cultured; Mice, Inbred C57BL; Propanolamines; Propranolol; Receptor, Angiotensin, Type 1; Receptors, Adrenergic, beta-2; Telmisartan | 2020 |
Chiral separation of beta-blockers by high-performance liquid chromatography and determination of bisoprolol enantiomers in surface waters.
Topics: Acebutolol; Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Chromatography, High Pressure Liquid; Labetalol; Metoprolol; Water | 2020 |
β-Blocker Use and Risk of Mortality in Heart Failure Patients Initiating Maintenance Dialysis.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Atenolol; Bisoprolol; Carvedilol; Cause of Death; Cohort Studies; Female; Heart Failure; Hospitalization; Humans; Kidney Failure, Chronic; Labetalol; Logistic Models; Male; Metoprolol; Middle Aged; Mortality; Nadolol; Proportional Hazards Models; Propranolol; Protective Factors; Renal Dialysis; Retrospective Studies; Risk; Risk Factors | 2021 |
Hair analysis for beta-blockers and calcium-channel blockers by using liquid chromatography-tandem mass spectrometry as a tool for monitoring adherence to antihypertensive therapy.
Topics: Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Atenolol; Bisoprolol; Calcium; Calcium Channel Blockers; Chromatography, Liquid; Hair Analysis; Humans; Labetalol; Metoprolol; Nadolol; Nebivolol; Reproducibility of Results; Sotalol; Tandem Mass Spectrometry | 2022 |
Co-prescription of metoprolol and CYP2D6-inhibiting antidepressants before and after implementation of an optimized drug interaction database in Norway.
Topics: Antidepressive Agents; Atenolol; Bisoprolol; Bupropion; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Drug Interactions; Drug Prescriptions; Fluoxetine; Humans; Metoprolol; Paroxetine; Retrospective Studies | 2022 |
Further exploration of the collision-induced dissociation of select beta blockers: Acebutolol, atenolol, bisoprolol, carteolol, and labetalol.
Topics: Acebutolol; Atenolol; Bisoprolol; Carteolol; Chromatography, Liquid; Labetalol; Tandem Mass Spectrometry | 2023 |